RxNorm 1368431 NDC Crossover
alogliptin 25 MG / pioglitazone 30 MG Oral Tablet
Related NDC Codes to RxNorm Concept 1368431
The following NDC codes crossover to the RxNorm Concept 1368431. This list is useful when crossing over from a given RxNorm code and the user is trying to choose a drug or product included in the NDC directory.
| NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Labeler Name | Status | |
|---|---|---|---|---|---|---|---|
| 45802-238 | Alogliptin And Pioglitazone | Padagis Israel Pharmaceuticals Ltd | |||||
| 45802-260 | Alogliptin And Pioglitazone | Alogliptin Benzoate And Pioglitazone Hydrochloride | Tablet, Film Coated | Oral | Padagis Israel Pharmaceuticals Ltd | ACTIVE | |
| 45802-304 | Alogliptin And Pioglitazone | Padagis Israel Pharmaceuticals Ltd | |||||
| 45802-351 | Alogliptin And Pioglitazone | Alogliptin Benzoate And Pioglitazone Hydrochloride | Tablet, Film Coated | Oral | Padagis Israel Pharmaceuticals Ltd | ACTIVE | |
| 45802-402 | Alogliptin And Pioglitazone | Alogliptin Benzoate And Pioglitazone Hydrochloride | Tablet, Film Coated | Oral | Padagis Israel Pharmaceuticals Ltd | ACTIVE | |
| 45802-499 | Alogliptin And Pioglitazone | Alogliptin Benzoate And Pioglitazone Hydrochloride | Tablet, Film Coated | Oral | Padagis Israel Pharmaceuticals Ltd | ACTIVE | |
| 64764-123 | Oseni | Alogliptin And Pioglitazone | Tablet, Film Coated | Oral | Takeda Pharmaceuticals America, Inc. | ACTIVE | |
| 64764-251 | Oseni | Alogliptin And Pioglitazone | Tablet, Film Coated | Oral | Takeda Pharmaceuticals America, Inc. | ACTIVE | |
| 64764-253 | Oseni | Alogliptin And Pioglitazone | Tablet, Film Coated | Oral | Takeda Pharmaceuticals America, Inc. | ACTIVE | |
| 64764-254 | Oseni | Alogliptin And Pioglitazone | Tablet, Film Coated | Oral | Takeda Pharmaceuticals America, Inc. | ACTIVE |
